Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR:LSE) Annual Income Statement ()
XSDR:LSE Quarterly Financials ()
Frequently Asked Questions About Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (XSDR:LSE) Stock
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's (XSDR:LSE) last reported annual revenue was N/A.
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's (XSDR:LSE) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) is not profitable as of its last reported annual financials.
The net profit margin for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) from its laster reported year is N/A
The return on equity (ROE) for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) from its last reported annual financials is : N/A
The return on assets (ROA) for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) from its last reported annual financials is : N/A
The Debt to Equity ratio for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) from its last reported annual financials is : N/A
The dividend yield for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) from its laster reported year is 2.60%
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C's(XSDR:LSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for XSDR:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
